Education
About Us
Working with TipRanks
Follow Us
Longeveron (LGVN)
NASDAQ:LGVN
Earnings Data
Report Date
Mar 06, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.37Last Year’s EPS
-0.43Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture for Longeveron. While there were significant advancements in clinical trials and a robust pipeline with favorable FDA designations, the company also faces financial challenges, including declining revenues, increased expenses, and potential delays in regulatory filings. Longeveron is actively seeking partnerships and additional funding to address these challenges.Company Guidance
Progress in HLHS Clinical Trial
Completed enrollment of the Phase IIb ELPIS II clinical trial in HLHS, a key strategic priority with a clear regulatory path to potential approval and commercialization pending results in Q3 2026.
Strong Pipeline and FDA Designations
Longeveron has a robust pipeline with programs in HLHS, Alzheimer's disease, and pediatric dilated cardiomyopathy, and has received five important FDA designations across these programs.
Partnership and Financial Opportunities
Longeveron is actively seeking partnerships and additional financing options to support its development programs, leveraging its pipeline and near-term milestones.
Positive Initial Results in Multiple Trials
Laromestrocel has shown positive initial results across five clinical trials in three different indications, indicating a strong potential for future breakthroughs.
LGVN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LGVN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 04, 2025 | $0.80 | $0.76 | -5.00% |
Aug 13, 2025 | $0.86 | $0.76 | -11.63% |
May 08, 2025 | $1.49 | $1.34 | -10.07% |
Feb 28, 2025 | $1.52 | $1.38 | -9.21% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Longeveron (LGVN) report earnings?
Longeveron (LGVN) is schdueled to report earning on Mar 06, 2026, Before Open (Confirmed).
What is Longeveron (LGVN) earnings time?
Longeveron (LGVN) earnings time is at Mar 06, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LGVN EPS forecast?
LGVN EPS forecast for the fiscal quarter 2025 (Q4) is -0.37.